Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age
Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to < 18 years of age).
Inclusion Criteria:
Exclusion Criteria:
ClinicalTrials.gov_Inquiries@pfizer.com1-800-718-1021
La Jolla, California 93037, United States
Long Beach, California 90806, United States
North Hollywood, California 91606, United States
Sacramento, California 95817, United States
Sacramento, California 95817, United States
Sacramento, California 95817, United States
Upland, California 91786, United States
Aurora, Colorado 80045, United States
Colorado Springs, Colorado 80907, United States
Colorado Springs, Colorado 80919, United States
Stamford, Connecticut 06905, United States
Washington D.C., District of Columbia 20010, United States
Orange Park, Florida 32073, United States
West Palm Beach, Florida 33407, United States
Grand Rapids, Michigan 49503, United States
Grand Rapids, Michigan 49503, United States
Ozark, Missouri 65721, United States
New York, New York 10029, United States
New York, New York 10032, United States
New York, New York 10032, United States
Grants Pass, Oregon 97527, United States
Portland, Oregon 97225, United States
Philadelphia, Pennsylvania 19104, United States
Greenville, South Carolina 29615, United States
Memphis, Tennessee 38103, United States
Memphis, Tennessee 38103, United States
Austin, Texas 78749, United States
Frisco, Texas 75034, United States
Salt Lake City, Utah 84107, United States
Charlottesville, Virginia 22902, United States
Charlottesville, Virginia 22902, United States
Seattle, Washington 98105, United States
Katowice, 40-123, Poland
Krakow, 31-503, Poland
Balenya, Barcelona 08550, Spain